Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 9, 2000

View Archived Issues

Positive interim phase I/II data shown for Multikine in head and neck cancer

HumaRAD pilot clinical results reported for head and neck cancer

Cypress Bioscience expands Prosorba Column pilot program

MSI-ipratropium trial reveals efficacy of new delivery system

Insulin and sildenafil restore gastrointestinal function in diabetic mice

Suppression of mitochondrial respiration linked to osteoarthritis

Chemotherapy of head and neck cancer enhanced by gene therapy

Tamoxifen plus cisplatin improves survival in melanoma patients

CNS-reactive human MAbs promote remyelination in MS model

Genasense receives orphan drug status for treatment of malignant melanoma

MediChem-AstraZeneca collaboration extended

Phase II study of clenoliximab in rheumatoid arthritis begins

Collateral expands research collaboration with NYU

Sankyo develops rosiglitazone analogues with hypoglycemic activities

Novel growth factor receptor inhibitors described by Sugen

Prous Science selected official internet and multimedia provider for XXII ESC Congress

Pulmicort Respules approved in U.S. for children aged 1 to 8 years

New peptides under development at Ludwig Institute

Roche discloses new series of IP receptor agonists

New antiangiogenic agents under development at Merck KGaA

Nycomed Imaging describes new compounds as contrast media

MTP inhibitors under development at Janssen

New polypeptides useful for treatment of metastases

Kogenate Bayer approved in E.U. for hemophilia A

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...